Jpmorgan Chase & CO A Tyr Pharma Inc Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in A Tyr Pharma Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 20,686 shares of LIFE stock, worth $38,475. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,686
Previous 33,854
38.9%
Holding current value
$38,475
Previous $66,000
51.52%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding LIFE
# of Institutions
49Shares Held
38.4MCall Options Held
200Put Options Held
4.6K-
Federated Hermes, Inc. Pittsburgh, PA14.7MShares$27.3 Million0.06% of portfolio
-
Logos Global Management LP San Francisco, CA3MShares$5.58 Million0.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.65MShares$4.93 Million0.0% of portfolio
-
Tikvah Management LLC Charlotte, NC2.46MShares$4.58 Million1.27% of portfolio
-
Checkpoint Capital L.P. San Francisco, CA1.95MShares$3.62 Million1.83% of portfolio
About aTYR PHARMA INC
- Ticker LIFE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,625,000
- Market Cap $53.2M
- Description
- aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...